SomnoMed (SOM:LSE) Annual Reports & Investor Relations Material

Overview

SomnoMed is the leading company in the global market for Open Airway Therapy (OAT) devices that treat obstructive sleep apnea in a safe and effective manner. The company has been at the forefront of OSA treatment innovation since 2004, providing customized devices that prioritize patient comfort and therapy effectiveness. SomnoMed is committed to collaborating with dental and healthcare professionals to ensure 100% therapy compliance and promote better sleep health for individuals suffering from mild-to-moderate sleep apnea.

Frequently Asked Questions

What is SomnoMed's ticker?

SomnoMed's ticker is SOM

What exchange is SomnoMed traded on?

The company's shares trade on the LSE stock exchange

Where are SomnoMed's headquarters?

They are based in Fort Myers, Florida

How many employees does SomnoMed have?

There are 51-200 employees working at SomnoMed

What is SomnoMed's website?

It is https://somnomed.com/

What type of sector is SomnoMed?

SomnoMed is in the Industrial Goods sector

What type of industry is SomnoMed?

SomnoMed is in the Farm & Construction Machinery industry

Who are SomnoMed's peers and competitors?

The following five companies are SomnoMed's industry peers:

- PPK Group Limited

- Growth International

- Deliveroo

- Terex

- Gencor Industries Inc.